MarginsXMarginsX
Home › Markets › GWLL

Goldenwell Biotech, Inc. (GWLL)

GWLL is quoted over the counter, not listed on an exchange. Goldenwell Biotech, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Last trade · November 10, 2026
$0.6000
No trades since Nov 10, 2026; later closes repeat the last quote
1-year return
-70.1%
Market cap
$59.4M
Micro cap. From the Nov 10, 2026 last trade × 99M shares (10-Q cover page, Aug 11, 2026)
P/E and P/S
Net loss over the period · 1080000.0×
On trailing twelve months to June 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerGWLL, quoted over the counter
SEC CIK0001800373
OTC Markets tierOTCQB (price source, 2026-11-13)
SEC industry codeFood and Kindred Products
Business addressSolon, OH
Incorporated inNV

Warning signs

Cash runway
1.2 months
$11K cash at June 30, 2026
Share count, 1 year
0.0%
2025-09-11 to 2026-08-11 · 0.0% over 3 years
Going-concern doubt
Yes
10-Q filed August 14, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time."
10-Q 2026-08-14
Cash and burn$11K cash; operating cash flow -$28K a quarter.Report 2026-06-30
Shares outstanding99,000,000 (2026-08-11); 99,000,000 a year earlier; 99,000,000 three years earlier.Cover page 2026-08-11
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorMICHAEL GILLESPIE & ASSOCIATES, PLLC, VANCOUVER, Washington, United States; changed auditors 3 times in 24 months8-K 4.01 2026-09-29
Late filings, 12 months2 NT noticesNT 10-Q 2026-05-12
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$0-$37K-$47K$11KNo debt tags$5510-Q 2026-08-14
Q1 2026
2026-03-31
$0-$18K-$13K$13KNo debt tags$5510-Q 2026-07-01
Q4 2025
2025-12-31
$55-$200K-$19K$27KNo debt tags$5510-K 2026-07-01
Q3 2025
2025-09-30
$0-$28K-$31K$46KNo debt tags$010-Q 2025-12-08
Q2 2025
2025-06-30
$0-$30K$59K$77KNo debt tags$010-Q 2026-08-14
Q1 2025
2025-03-31
$0-$39K-$32K$17K$176K$13910-Q 2026-07-01
Q4 2024
2024-12-31
$0-$27K-$25K$49K$174K$13910-K 2026-07-01
Q3 2024
2024-09-30
$0-$23K-$21K$5KNo debt tags$39910-Q/A 2026-06-29

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32020-11-23
Latest annual report10-K2026-07-01
Latest quarterly / interim10-Q2026-11-16
Latest current report8-K2026-10-09

Source: SEC EDGAR submissions feed, 86 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier